Intrinsiqq
Metropolitan Bank Holding Corp. logo

Metropolitan Bank Holding Corp. Insider Trading

MCB

⊜ Compare
Last 12 months

Insiders bought 170K and sold $4.53M on the open market.

9% of the selling was scheduled in advance under 10b5-1 plans. Director Robert C Patent sold $1.36M on Jan 23, 12% of their stake, outside a plan.

Net open-market
−$4.36M
2 buys · 10 sales
Under a 10b5-1 plan
9%
of the value sold
Insiders who bought / sold
1 / 4
executives and directors
Last open-market buy
Jul 2026
Jul 23, 2026

Get an email when MCB's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Sep 17No plan
    Dale C Fredston
    Director · sold 2,000 at $89.09
    178K
    12% of stake
  • Aug 10No plan
    Robert C Patent
    Director · sold 10,000 at $92.29
    923K
    12% of stake
  • Jul 23
    Daniel F Dougherty
    EVP & Chief Financial Officer · bought 1,000 at $89.98
    90K
    3.1% of stake
  • Jun 30 – Jul 110b5-1 plan
    Nick Rosenberg
    Executive Vice President · sold 1,897 at avg $100.41
    190K
    7.7% of stake
  • Jun 26 – 2910b5-1 plan
    Nick Rosenberg
    Executive Vice President · sold 353 at avg $100.02
    35K
    1.4% of stake
  • Jun 12No plan
    Robert C Patent
    Director · sold 10,000 at $96.41
    964K
    10% of stake
  • Jun 4No plan
    Robert C Patent
    Director · sold 5,000 at $90.21
    451K
    4.9% of stake
  • May 29No plan
    Harvey Gutman
    Director · sold 3,000 at $89.58
    269K
    14% of stake
  • Mar 10
    Daniel F Dougherty
    EVP & Chief Financial Officer · bought 1,000 at $79.95
    80K
    3.1% of stake
  • Jan 22 – 23No plan
    Robert C Patent
    Director · sold 14,445 at avg $94.16
    $1.36M
    12% of stake
  • Jan 2110b5-1 plan
    Nick Rosenberg
    Executive Vice President · sold 1,250 at $90.21
    113K
    4.5% of stake
  • Dec 10, 202510b5-1 plan
    Nick Rosenberg
    Executive Vice President · sold 625 at $80.41
    50K
    2.2% of stake
  • Oct 30, 2025
    Anthony J Fabiano
    Director · bought 147 at $67.87
    10K
    1.2% of stake
  • Oct 27, 2025
    Daniel F Dougherty
    EVP & Chief Financial Officer · bought 1,000 at $71.66
    72K
    3.7% of stake
  • Oct 27, 2025
    Frederik F Erikson
    EVP & General Counsel · bought 20 at $68.65
    1K
    0.3% of stake
  • Oct 20, 202510b5-1 plan
    Scott Lublin
    EVP and Chief Lending Officer · sold 5,000 at avg $74.36
    372K
    11% of stake
  • Oct 17, 202510b5-1 plan
    Nick Rosenberg
    Executive Vice President · sold 625 at avg $72.47
    45K
    2.2% of stake
  • Sep 17, 202510b5-1 plan
    Nick Rosenberg
    Executive Vice President · sold 1,250 at avg $79.47
    99K
    4.1% of stake
  • Sep 3, 2025No plan
    Dale C Fredston
    Director · sold 3,000 at avg $78.65
    236K
    17% of stake
  • Aug 27, 2025No plan
    Robert C Patent
    Director · sold 5,000 at $79.02
    395K
    3.3% of stake
  • Aug 19, 2025No plan
    Terence J Mitchell
    Director · sold 4,796 at $72.44
    347K
    27% of stake
  • Aug 19, 2025No plan
    Robert C Patent
    Director · sold 5,000 at $72.75
    364K
    3.2% of stake
  • Jul 22, 2025No plan
    Harvey Gutman
    Director · sold 1,400 at $78.41
    110K
    7.0% of stake
  • Jul 21, 202510b5-1 plan
    Scott Lublin
    EVP and Chief Lending Officer · sold 5,000 at avg $78.64
    393K
    9.8% of stake
  • Jul 21, 2025No plan
    Robert C Patent
    Director · sold 10,000 at avg $78.52
    785K
    6.0% of stake
  • Jul 3, 202510b5-1 plan
    Nick Rosenberg
    Executive Vice President · sold 1,250 at $75.05
    94K
    4.0% of stake
  • Jun 20, 202510b5-1 plan
    Scott Lublin
    EVP and Chief Lending Officer · sold 5,000 at avg $65.03
    325K
    8.9% of stake
  • Jun 18, 2025No plan
    Robert C Patent
    Director · sold 2,000 at $65.61
    131K
    1.2% of stake
  • Jun 10, 2025No plan
    Mark R Defazio
    President and CEO · sold 43,631 at avg $65.43
    $2.85M
    31% of stake
  • Apr 23, 2025 – May 2, 2025No plan
    Dixiana M Berrios
    EVP & Chief Operating Officer · sold 6,276 at avg $63.97
    401K
    32% of stake
  • Apr 25, 2025No plan
    Norman Scott
    SVP and Chief Credit Officer · sold 3,293 at $60.57
    199K
    21% of stake
  • Mar 17, 2025No plan
    Scott Lublin
    EVP and Chief Lending Officer · sold 5,000 at $54.60
    273K
    9.1% of stake
  • Mar 17, 2025No plan
    Mark R Defazio
    President and CEO · sold 18,421 at avg $54.78
    $1.01M
    13% of stake
  • Feb 20, 2025No plan
    Katrina Robinson
    Director · sold 3,563 at $60.45
    215K
    42% of stake
  • Feb 13, 2025No plan
    Dale C Fredston
    Director · sold 1,000 at $62.27
    62K
    5.5% of stake
  • Dec 19, 2024No plan
    Scott Lublin
    EVP and CLO · sold 3,000 at $58.77
    176K
    5.4% of stake
  • Nov 11, 202410b5-1 plan
    Nick Rosenberg
    Executive Vice President · sold 1,250 at $65.17
    81K
    3.9% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch MCB, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

State Commercial Banks · Pick stocks to compare with MCB

CompareIntrinsic value
BFSTBusiness First Bancshares, Inc.
$32.98+2.23%62
PEBOPeoples Bancorp Inc.
$39.84+2.26%64
NTRSNorthern Trust Corporation
$172.60+1.14%88
STTState Street Corp
$173.41+2.18%83
BOHBank of Hawaii Corporation
$71.20+1.38%63
UVSPUnivest Financial Corporation
$41.24-0.12%83
ALLYAlly Financial Inc.
$39.36+3.80%58
BWFGBankwell Financial Group Inc.
$73.27+2.22%72

Held by ETFs

MCB is in 51 US ETFs. The largest of them, with MCB's weight in each:

Spot a number that looks wrong? Check it in MCB's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing MCB

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.